For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Applications
IgG Dog Reduced Jupiter C4 300
14909
Separation Mode: Reversed Phase
Reversed Phase
C4
HPLC
Pharmaceutical/Biopharmaceutical
Life Science
Protein
Biochemical Compound / Nutrient

Applications

IgG Dog Reduced Jupiter C4 300
Analytes
1IgG

Analyte not found

Details
LC Conditions (App ID: 14909)
Column:
Brand Name:
Part No:
Phase Name:
C4
Elution Type:
Gradient
Mobile Phase:
A: 0.1% TFA in Water/Acetonitrile (95:5)
B: 0.085%TFA in Acetonitrile/IPA/Water (75:20:5)
Gradient Profile:
Step No.Time(min)%A%B
108020
220595
Flow Rate:
0.25 mL/min
Temperature:
22°C
Detection:
UV-Vis Abs.-Diode Array (PDA) @ 220 nm (22°C)
Sample Note:
Application Focus: Reducing antibodies to separate heavy and light chains by Jupiter C4 While using IPA in the organic mobile phase can help improve the chromatography of Ig-G, often the best way to observed changes in immunoglobins is by reducing the proteins and separating the heavy and light chain of the protein and analyzing them by HPLC on a Jupiter C4 column. Key to get complete reduction of a protein is to perform the reduction in a chaotrope (either urea or guanidine) to unfold the protein thus breaking up any non-covalent interactions. Upon incubation with DTT, BME or some other reducing reagent, Ig-G heavy and light chains are released and can by separated by HPLC. In this example, dog Ig-G was reduced with 2 mM dithiothreitol in 8 M Urea at 45º C for 30 minutes. In this example dog Ig-G was reduced with dithiothreitol and injected on a Jupiter 300 C4 column. As shown in App ID# 14909, one can see the heavy and light chains are baseline resolved using the conditions discussed in length in App ID#14908 (20% IPA in the organic mobile phase and elevated temperature). These results demonstrate the ability of the Jupiter 300 C4 to resolve differences between large hydrophobic proteins for demanding applications such as the separation of immunoglobulin proteins.

Order Items Used in This Application

Similar Applications
search
Aeris 3.6 µm WIDEPORE XB-C8 200 Å, LC Column 100 x 2.1 mm, Ea
Reversed Phase
Aeris 3.6 µm WIDEPORE XB-C8 200 Å, LC Column 100 x 2.1 mm, Ea
Reversed Phase
Aeris 3.6 µm WIDEPORE XB-C8 200 Å, LC Column 100 x 2.1 mm, Ea
Reversed Phase
Aeris 3.6 µm WIDEPORE XB-C8 200 Å, LC Column 100 x 2.1 mm, Ea
Reversed Phase
Aeris 3.6 µm WIDEPORE XB-C18 200 Å, LC Column 150 x 4.6 mm, Ea
Reversed Phase
Aeris 3.6 µm PEPTIDE XB-C18 100 Å, LC Column 150 x 2.1 mm, Ea
Reversed Phase
Aeris 3.6 µm PEPTIDE XB-C18 100 Å, LC Column 150 x 4.6 mm, Ea
Reversed Phase